Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 11, 2022
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countriesOlina EfthymiadouBMC Health Services Research|August 20, 2022
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countriesOlina Efthymiadou, Panos KanavosInternational Journal of Technology Assessment in Health Care|January 29, 2021
Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countriesOlina Efthymiadou, Panos KanavosInternational Journal of Technology Assessment in Health Care|September 26, 2018
DIFFERENTIATION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES BETWEEN FIVE DISEASE AREAS: RESULTS FROM AN INTERNATIONAL SURVEY OF PATIENTSOlina Efthymiadou, Jean Mossman, Panos KanavosHealth Policy (Amsterdam, Netherlands)|January 2, 2019
Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patientsOlina Efthymiadou, Jean Mossman, Panos KanavosThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 5, 2019
Does external reference pricing deliver what it promises? Evidence on its impact at national levelPanos Kanavos, Anna-Maria Fontrier, Jennifer Gill, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2017
Using IMPrESS to guide policy change in multiple sclerosisMichela Tinelli, Panos Kanavos, Olina Efthymiadou, et al.Journal of Neurology|April 25, 2026
Patient-reported outcomes and experiences with COMT inhibitors in the management of motor fluctuations in Parkinson's disease: a UK-based nested cross-sectional studyAlastair J Noyce, Lara Akindele, Emma-Louise Shelton, et al.Pageof 1